Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares

Bulletin Express03-03

On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the announcement, the highest trading price during the repurchase was RMB 54.27 per share, and the lowest was RMB 53.52 per share, for a total consideration of RMB 33.98 million.

Following the repurchase, the company’s issued shares stand at 6.37 billion, with 6.79 million treasury shares, resulting in total shares of 6.38 billion. This repurchase was conducted on the Shanghai Stock Exchange as part of the A Share Employee Stock Ownership Schemes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144312966?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144312966","market":"hk","top_or_hot":-1,"title":"Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares","media":"Bulletin Express","content":"<p>On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the announcement, the highest trading price during the repurchase was RMB 54.27 per share, and the lowest was RMB 53.52 per share, for a total consideration of RMB 33.98 million.</p>\n<p>Following the repurchase, the company’s issued shares stand at 6.37 billion, with 6.79 million treasury shares, resulting in total shares of 6.38 billion. This repurchase was conducted on the Shanghai Stock Exchange as part of the A Share Employee Stock Ownership Schemes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-03 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the announcement, the highest trading price during the repurchase was RMB 54.27 per share, and the lowest was RMB 53.52 per share, for a total consideration of RMB 33.98 million.</p>\n<p>Following the repurchase, the company’s issued shares stand at 6.37 billion, with 6.79 million treasury shares, resulting in total shares of 6.38 billion. This repurchase was conducted on the Shanghai Stock Exchange as part of the A Share Employee Stock Ownership Schemes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1144312966","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144312966","pubTimestamp":1772529746,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"江苏恒瑞医药(600276)公告回购股份及更新已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the announcement, the highest trading price during the repurchase was RMB 54.27 per share, and the lowest was RMB 53.52 per share, for a total consideration of RMB 33.98 million.\nFollowing the repurchase, the company’s issued shares stand at 6.37 billion, with 6.79 million treasury shares, resulting in total shares of 6.38 billion. This repurchase was conducted on the Shanghai Stock Exchange as part of the A Share Employee Stock Ownership Schemes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144312966","isCrawlerRequest":true}